Immuno AG

Immuno AG was a major[1] pharmaceutical company founded in 1960 by Dr. Otto Schwarz & Dr. Hans Eibl[2] with headquarters in Vienna, Austria.[3]

In 1996 the company was acquired by Baxter for $715 million.[4]

Business

Immuno manufactured blood products including factor VIII and factor IX[5] such as Kryobulin and Krobulin TIM.[6]

Lawsuits

In 1983 Immuno sued Dr. Shirley McGreal and several others claiming $4 million in damages for an article claiming the company planned to use captured chimpanzees for hepatitis research in Sierra Leone.[7][8]

In 1986 two civil lawsuits were brought against Immuno by the Association Against Animal Experimentation in regard to treatment of chimpanzees.[9]

The plant in Krems, which was set up in 2002 but never went into operation, was subjected to an examination of its further usability in the course of 2013. The partial expansion was announced in autumn 2013: "In the first expansion stage, a production line is initially planned, and there is sufficient space for possible future expansions. The investment volume is estimated at 138 million euros. The start of construction is planned for the first quarter of 2014."[10]

References

Whiteside, R. M.; Wilson, A.; Blackburn, S.; Hörnig, S. E.; Wilson, C. P. (6 December 2012). Major Companies of Europe 1990/91 Volume 3: Major Companies of Western Europe Outside the European Economic Community. Springer Science & Business Media. ISBN 9789400908017 – via Google Books.
Stern, Joe. "In Memoriam of Dr. Otto Schwarz - Plasma Protein Therapeutics Association (PPTA)".
"Immuno AG".
Thomas M. Burton (30 August 1996). "Baxter Confirms Pact To Acquire Immuno". Wall Street Journal.
"Method of producing a factor-VIII(AHF)-high-concentrate".
"Final Report: Chapter 23 - Viral Inactivation of Blood Products for Haemophilia Therapy up to 1985".
"Abroad at Home; Abusing The Law". The New York Times. 10 May 1991.
"IMMUNO, A.G., APPELLANT, v. JAN MOOR-JANKOWSKI, RESPONDENT".
Information, Reed Business (21 August 1986). "New Scientist". Reed Business Information – via Google Books. {{cite web}}: |first= has generic name (help)
"Baxter Österreich - News & Medien - Pressemitteilungen - 2013 - Gesundheitsunternehmen Baxter investiert in Pharmaproduktion in Krems". 2014-05-06. Archived from the original on 2014-05-06. Retrieved 2022-08-19.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Whiteside, R. M.; Wilson, A.; Blackburn, S.; Hörnig, S. E.; Wilson, C. P. (6 December 2012). Major Companies of Europe 1990/91 Volume 3: Major Companies of Western Europe Outside the European Economic Community. Springer Science & Business Media. ISBN 9789400908017 – via Google Books.

[2] Stern, Joe. "In Memoriam of Dr. Otto Schwarz - Plasma Protein Therapeutics Association (PPTA)".

[3] "Immuno AG".

[4] Thomas M. Burton (30 August 1996). "Baxter Confirms Pact To Acquire Immuno". Wall Street Journal.

[5] "Method of producing a factor-VIII(AHF)-high-concentrate".

[6] "Final Report: Chapter 23 - Viral Inactivation of Blood Products for Haemophilia Therapy up to 1985".

[7] "Abroad at Home; Abusing The Law". The New York Times. 10 May 1991.

[8] "IMMUNO, A.G., APPELLANT, v. JAN MOOR-JANKOWSKI, RESPONDENT".

[9] Information, Reed Business (21 August 1986). "New Scientist". Reed Business Information – via Google Books. {{cite web}}: |first= has generic name (help)

[10] "Baxter Österreich - News & Medien - Pressemitteilungen - 2013 - Gesundheitsunternehmen Baxter investiert in Pharmaproduktion in Krems". 2014-05-06. Archived from the original on 2014-05-06. Retrieved 2022-08-19.